Trial
NCT03576547
Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Intervention
Dexamethasone
Why stopped
The study was terminated early due to slow accrual and low level of interest both by the sponsor and by the department
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-08